97 related articles for article (PubMed ID: 8038359)
21. Maintenance therapies for reflux esophagitis.
Yarze JC
N Engl J Med; 1996 Feb; 334(9):600-1. PubMed ID: 8569839
[No Abstract] [Full Text] [Related]
22. [The omeprazole treatment of patients with diseases of the upper digestive tract].
Degtiareva II; Zukheĭr Kh; Lodianaia EV; Palladina OL; Nevstruev VP; Piletskiĭ AM; Chervak IN
Lik Sprava; 1994; (7-8):117-20. PubMed ID: 7900331
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiology of reflux oesophagitis and peptic ulcer.
Gabryelewicz A
J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):23-40. PubMed ID: 8260733
[TBL] [Abstract][Full Text] [Related]
24. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
[TBL] [Abstract][Full Text] [Related]
25. Low-dose omeprazole for erosive esophagitis.
Epling J; Taylor H
J Fam Pract; 1999 Feb; 48(2):93-4. PubMed ID: 10037536
[No Abstract] [Full Text] [Related]
26. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
27. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
28. Medical treatment of reflux esophagitis.
Olbe L; Lundell L
Hepatogastroenterology; 1992 Aug; 39(4):322-4. PubMed ID: 1427576
[No Abstract] [Full Text] [Related]
29. [A study on reflux esophagitis--clinical nonsense].
Jaup BH
Lakartidningen; 1992 Sep; 89(40):3270. PubMed ID: 1405942
[No Abstract] [Full Text] [Related]
30. Experimental oesophagitis in the rat is associated with decreased voluntary movement.
Miwa H; Oshima T; Sakurai J; Tomita T; Matsumoto T; Iizuka S; Koseki J
Neurogastroenterol Motil; 2009 Mar; 21(3):296-303. PubMed ID: 19126182
[TBL] [Abstract][Full Text] [Related]
31. Treatment of refractory ulcerative oesophagitis with omeprazole.
Dalzell AM; Searle JW; Patrick MK
Arch Dis Child; 1992 May; 67(5):641-2. PubMed ID: 1599306
[TBL] [Abstract][Full Text] [Related]
32. [Acid inhibitors for asthma patients].
Füessl HS
MMW Fortschr Med; 2005 Oct; 147(42):4-5. PubMed ID: 16281772
[No Abstract] [Full Text] [Related]
33. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
[TBL] [Abstract][Full Text] [Related]
34. Reflux oesophagitis in children; the role of endoscopy. A multicentric Italian survey.
Lombardi G; de' Angelis G; Rutigliano V; Guariso G; Romano C; Falchetti D; Pittschieler K; Brunero M; Lerro P; Sabbi T; Pepe G; De Venuto D; Torroni F; Bizzarri B; Di Nicola M; Di Mascio R; Dall'Oglio L
Dig Liver Dis; 2007 Sep; 39(9):864-71. PubMed ID: 17681873
[TBL] [Abstract][Full Text] [Related]
35. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
36. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
Arnold R
Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
[No Abstract] [Full Text] [Related]
37. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
38. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
[No Abstract] [Full Text] [Related]
39. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
[TBL] [Abstract][Full Text] [Related]
40. The impact of omeprazole and laparoscopy upon hiatal hernia and reflux esophagitis.
McKenzie D; Grayson T; Polk HC
J Am Coll Surg; 1996 Oct; 183(4):413-8. PubMed ID: 8843275
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
